Skip to main content
. Author manuscript; available in PMC: 2013 May 10.
Published in final edited form as: Pharmacotherapy. 2011 Jul;31(7):678–685. doi: 10.1592/phco.31.7.678

Table 1.

Demographics

Parameter Prophylaxis (n=13 cases) Therapeutic* (n=40 cases)
Age (mean, years ± SD) 27.4 ± 7.5 27.7 ± 6.1
Race
 African-American (n,%) 7 (53.8%) 26 (65%)
 Hispanic (n,%) 5 (38.5%) 10 (25%)
 Other (n,%) 1 (7.7%) 4 (10%)
Nulliparity (n,%) 5 (38.5%) 6 (15%)
Initial weight at start of LMWH (mean, kg ±SD) 85.3 ± 25.6 89.9 ± 29.3
Weight gain during pregnancy (mean, kg ± SD, range) 6.2 ± 3.7 (1.4–14.1) (n=12) 8.6 ± 14.1 (−6.0 – 85) (n = 37)
Pre-pregnancy BMI > 30 kg/m2 (n,%) 6 (30.8%) 24 (60%)
Health insurance status
 Public Aid (n,%) 9 (69.2%) 22 (55%)
 HMO/PPO (n,%) 3 (23.1%) 19 (45%)
 Other (n,%) 1 (7.7%) 0
Trimester LMWH started
 First (n, %) 2 (15.4%) 21 (52.5%)
 Second (n, %) 9 (60%) 13 (7.5%)
 Third (n, %) 2 (15.4%) 6 (15%)
*

Therapeutic group includes patients with MVR

BMI = Body Mass Index

HMO = Health Maintenance Organization

PPO = Preferred Provider Organization